Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapeutic Effect and Prognosis Predication Related Immunocyte Subgroup and Immunologic Factors Screeing for Colorectal Cancer

NCT02222753 is registered in ClinicalTrials.gov with State Key Laboratory of Cancer Biology as lead sponsor.

NCT NCT02222753
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02222753 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapeutic Effect and Prognosis Predication Related Immunocyte Subgroup and Immunologic Factors Screeing for Colorectal Cancer
Lead sponsor
State Key Laboratory of Cancer Biology
Phase
Observational
Overall status
Unknown status
Start date
January 31, 2014
Completion date
Not reported
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer